BrightSpring Health Services, Inc. Common Stock (BTSG) P/E Ratio History
Historical price-to-earnings valuation from 2025 to 2026
Loading P/E history...
BTSG Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 8, 2026, BrightSpring Health Services, Inc. Common Stock (BTSG) trades at a price-to-earnings ratio of 60.9x, with a stock price of $52.94 and trailing twelve-month earnings per share of $1.40.
The current P/E is 12% above its 5-year average of 54.4x. Over the past five years, BTSG's P/E has ranged from a low of 39.4x to a high of 76.5x, placing the current valuation at the 60th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.3x, BTSG trades at a 173% premium to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 177.5x.
The PEG ratio of 1.25 (P/E divided by 1029% EPS growth) suggests a fair valuation relative to its earnings growth. Peter Lynch popularized the rule that a PEG below 1.0 indicates an attractive entry point.
Relative to the broader market, BTSG commands a significant premium over the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our BTSG DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
BTSG P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $3B | 442.5 | - | +113%Best | |
| $10B | 29.8 | 2.16 | +14% | |
| $2B | 18.7 | 0.93 | +23% | |
| $3B | 16.3 | - | +3% | |
| $2B | 27.5 | - | +53% | |
| $2B | 13.9Lowest | - | -29% | |
| $92B | 29.2 | 0.75Best | +15% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
BTSG Historical P/E Data (2025–2026)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2026 Q1 | $42.59 | $1.08 | 39.4x | -27% | |
| FY2025 Q4 | Wed Dec 31 2025 00:00:00 GM | $37.45 | $0.88 | 42.6x | -22% |
| FY2025 Q3 | $29.56 | $0.61 | 48.5x | -11% | |
| FY2025 Q2 | Mon Jun 30 2025 00:00:00 GM | $23.59 | $0.31 | 76.5x | +41% |
| FY2025 Q1 | Mon Mar 31 2025 00:00:00 GM | $18.09 | $0.28 | 65.0x | +19% |
Average P/E for displayed period: 54.4x
Full BTSG Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See BTSG's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs BTSG Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare BTSG vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonBTSG — Frequently Asked Questions
Quick answers to the most common questions about buying BTSG stock.
Is BTSG stock overvalued or undervalued?
BTSG trades at 60.9x P/E, near its 5-year average of 54.4x. The 60th percentile ranking places valuation within normal historical bounds.
How does BTSG's valuation compare to peers?
BrightSpring Health Services, Inc. Common Stock P/E of 60.9x compares to sector median of 22.3x. The premium reflects expected growth above peers.
What is BTSG's PEG ratio?
BTSG PEG ratio is 1.25. Between 1-2 suggests valuation aligns with growth. Historical P/E data spans 2025-2026.